WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics
Titel:
WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics
Auteur:
Grauer, Steven M. Graf, Radka Navarra, Rachel Sung, Amy Logue, Sheree F. Stack, Gary Huselton, Christine Liu, Zhi Comery, Thomas A. Marquis, Karen L. Rosenzweig-Lipson, Sharon